Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models

Exenatide is used to treat patients with type-2 diabetes and it also exerts cardioprotective effects. Here, we tested whether Exenatide attenuates hyperglycemia-related cardiomyocyte damage by inhibiting endoplasmic reticulum (ER) stress and the NF-κB signaling pathway. Our results demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhenhong, Mui, David, Zhu, Hang, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244034/
https://www.ncbi.nlm.nih.gov/pubmed/32392536
http://dx.doi.org/10.18632/aging.103181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244034/
https://www.ncbi.nlm.nih.gov/pubmed/32392536
http://dx.doi.org/10.18632/aging.103181

Ejemplares similares